Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Community-based exercise for health promotion and secondary cancer prevention in Canada: protocol for a hybrid effectiveness-implementation study.

McNeely ML, Sellar C, Williamson T, Shea-Budgell M, Joy AA, Lau HY, Easaw JC, Murtha AD, Vallance J, Courneya K, Mackey JR, Parliament M, Culos-Reed N.

BMJ Open. 2019 Sep 13;9(9):e029975. doi: 10.1136/bmjopen-2019-029975.

2.

A Patient-Specific Anisotropic Diffusion Model for Brain Tumour Spread.

Swan A, Hillen T, Bowman JC, Murtha AD.

Bull Math Biol. 2018 May;80(5):1259-1291. doi: 10.1007/s11538-017-0271-8. Epub 2017 May 10.

PMID:
28493055
3.

Intraoperative factors associated with stranded source placement accuracy in low-dose-rate prostate brachytherapy.

Jamaluddin MF, Ghosh S, Waine MP, Tavakoli M, Amanie J, Murtha AD, Yee D, Usmani N.

Brachytherapy. 2017 May - Jun;16(3):497-502. doi: 10.1016/j.brachy.2017.01.007. Epub 2017 Feb 10.

PMID:
28190784
4.

Quantifying 125I placement accuracy in prostate brachytherapy using postimplant transrectal ultrasound images.

Jamaluddin MF, Ghosh S, Waine MP, Sloboda RS, Tavakoli M, Amanie J, Murtha AD, Yee D, Usmani N.

Brachytherapy. 2017 Mar - Apr;16(2):306-312. doi: 10.1016/j.brachy.2016.11.015. Epub 2017 Feb 1.

PMID:
28161433
5.

Moments of von Mises and Fisher distributions and applications.

Hillen T, Painter KJ, Swan AC, Murtha AD.

Math Biosci Eng. 2017 Jun 1;14(3):673-694. doi: 10.3934/mbe.2017038.

6.

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.

Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR, Barger GR, Coons S, Ricci P, Bullard D, Brown PD, Stelzer K, Brachman D, Suh JH, Schultz CJ, Bahary JP, Fisher BJ, Kim H, Murtha AD, Bell EH, Won M, Mehta MP, Curran WJ Jr.

N Engl J Med. 2016 Apr 7;374(14):1344-55. doi: 10.1056/NEJMoa1500925.

7.

Effectiveness of adjuvant temozolomide treatment in patients with glioblastoma.

Alnaami IM, Al-Nuaimi SK, Senthilselvan A, Murtha AD, Walling S, Mehta V, Gourishankar S.

Neurosciences (Riyadh). 2013 Oct;18(4):349-55.

PMID:
24141458
8.

Assessment of a commercially available automatic deformable registration system.

Fallone BG, Rivest DR, Riauka TA, Murtha AD.

J Appl Clin Med Phys. 2010 Jun 9;11(3):3175.

9.

Prostate positioning errors associated with two automatic registration based image guidance strategies.

Ryan D, Rivest C, Riauka TA, Murtha AD, Fallone BG.

J Appl Clin Med Phys. 2009 Oct 15;10(4):3071.

10.

Low-dose radiation hypersensitivity is associated with p53-dependent apoptosis.

Enns L, Bogen KT, Wizniak J, Murtha AD, Weinfeld M.

Mol Cancer Res. 2004 Oct;2(10):557-66.

11.

Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors.

Scrimger RA, Murtha AD, Parliament MB, Venner PM, Hanson J, Houle G, Chetner M.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):23-30.

PMID:
11516847
12.

Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University.

Murtha AD, Rupnow BA, Hansosn J, Knox SJ, Hoppe R.

Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):3-15. Erratum in: Int J Radiat Oncol Biol Phys 2001 May 1;50(1):285.

PMID:
11163492
13.

Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin.

Breitz HB, Fisher DR, Goris ML, Knox S, Ratliff B, Murtha AD, Weiden PL.

Cancer Biother Radiopharm. 1999 Oct;14(5):381-95.

PMID:
10850323
14.

Radiobiology of low-dose-rate radiation relevant to radioimmunotherapy.

Murtha AD.

Cancer Biother Radiopharm. 2000 Feb;15(1):7-14. Review.

PMID:
10740648
15.

Review of low-dose-rate radiobiology for clinicians.

Murtha AD.

Semin Radiat Oncol. 2000 Apr;10(2):133-8. Review.

PMID:
10727602
16.
17.

Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy.

Rupnow BA, Murtha AD, Alarcon RM, Giaccia AJ, Knox SJ.

Cancer Res. 1998 May 1;58(9):1779-84.

Supplemental Content

Loading ...
Support Center